Cocchi V, Sintoni C, Carretti D, Sama D, Chiari U, Segala V, Delazer A L, Grilli N, Papaleo R, Ghirardini C, Bucchi L
F. Addarii Cancer Institute, Bologna, Italy.
Acta Cytol. 1996 May-Jun;40(3):480-8. doi: 10.1159/000333903.
To evaluate the diagnostic agreement between seven cervical/vaginal cytology laboratories participating in the first external quality assurance (EQA) scheme developed in Italy.
Between 1991 and 1993, 110 cytologic smears were selected and classified by a committee and circulated and reported on by the laboratories according to the 1988 Bethesda System. Agreement was evaluated with the kappa statistic. Systematic disagreement was assessed by means of the Wilcoxon signed rank test.
Interlaboratory kappa values varied between .01 and .29 (group score, .11) for sample adequacy and between .53 and .78 (group score, .67) for epithelial abnormalities. The lowest specific kappa values were observed for the three classes of sample adequacy (unsatisfactory, .07; less than optimal [LTO], .10; satisfactory [SAT], .14) and for the class of atypical cells of undetermined significance (ACUS), (.29). As compared with the study committee, 5/7 laboratories showed a systematic (P<.01) tendency to undercall sample adequacy. Agreement on epithelial abnormalities was also analyzed according to the pattern of adequacy reported by paired laboratories (LTO/LTO, LTO/SAT, SAT/SAT). As compared with smears designated SAT/SAT, those classified as LTO/SAT were associated with lower specific kappa values for agreement on the presence of carcinoma and ACUS and with equal or greater values for agreement on the other classes, suggesting an arbitrary use of notations of LTO inversely related to the severity of epithelial lesions.
EQA schemes, as applied to cervical/vaginal cytology, can shed light on major deficiencies in specific diagnostic areas.
评估参与意大利首个外部质量保证(EQA)计划的7家宫颈/阴道细胞学实验室之间的诊断一致性。
在1991年至1993年期间,选取110份细胞学涂片由一个委员会进行分类,并由各实验室根据1988年贝塞斯达系统进行分发和报告。采用kappa统计量评估一致性。通过Wilcoxon符号秩检验评估系统差异。
实验室间样本充足性的kappa值在0.01至0.29之间(组评分,0.11),上皮异常的kappa值在0.53至0.78之间(组评分,0.67)。样本充足性的三个类别(不满意,0.07;次优[LTO],0.10;满意[SAT],0.14)以及意义不明确的非典型细胞(ACUS)类别(0.29)的kappa值最低。与研究委员会相比,7家实验室中有5家表现出系统的(P<0.01)低估样本充足性的倾向。还根据配对实验室报告的充足性模式(LTO/LTO、LTO/SAT、SAT/SAT)分析了上皮异常的一致性。与标记为SAT/SAT的涂片相比,分类为LTO/SAT的涂片在癌和ACUS存在的一致性方面具有较低的kappa值,而在其他类别上的一致性值相同或更高,这表明LTO标记的使用具有随意性,与上皮病变的严重程度呈负相关。
应用于宫颈/阴道细胞学的EQA计划可以揭示特定诊断领域的主要缺陷。